tradingkey.logo

MiMedx Group Inc

MDXG
View Detailed Chart

7.160USD

-0.030-0.42%
Close 08/01, 16:00ETQuotes delayed by 15 min
1.06BMarket Cap
26.36P/E TTM

MiMedx Group Inc

7.160

-0.030-0.42%
Intraday
1m
30m
1h
D
W
M
D

Today

-0.42%

5 Days

+5.76%

1 Month

+12.93%

6 Months

-16.16%

Year to Date

-25.57%

1 Year

+10.84%

View Detailed Chart

Agency Rating

Analyst Rating

Based on 5 analysts
BUY
Current Rating
12.200
Target Price
70.39%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

552
Total
5
Median
6
Average
Company name
Ratings
Analysts
MiMedx Group Inc
MDXG
5
CRISPR Therapeutics AG
CRSP
29
Intellia Therapeutics Inc
NTLA
28
Exact Sciences Corp
EXAS
27
Ionis Pharmaceuticals Inc
IONS
27
IQVIA Holdings Inc
IQV
25
1
2
3
...
111

Indicators

The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

1m
15m
30m
1h
D
W
M
1m
15m
30m
D
Buy
Sell(2)
Neutral(2)
Buy(9)
Indicators
Sell(1)
Neutral(2)
Buy(4)
Indicators
Value
Direction
MACD(12,26,9)
0.071
Buy
RSI(14)
61.075
Neutral
STOCH(KDJ)(9,3,3)
46.149
Neutral
ATR(14)
0.413
Low Volatility
CCI(14)
122.056
Buy
Williams %R
41.709
Buy
TRIX(12,20)
0.330
Sell
StochRSI(14)
94.320
Buy
Moving Average
Sell(1)
Neutral(0)
Buy(5)
Indicators
Value
Direction
MA5
6.866
Buy
MA10
6.829
Buy
MA20
6.758
Buy
MA50
6.471
Buy
MA100
6.848
Buy
MA200
7.575
Sell

News

More news coming soon, stay tuned...

Financial Indicators

EPS

No Data

Total revenue

No Data

Company

MiMedx Group, Inc. is a placental biologics company. The Company is engaged in developing and distributing placental tissue allografts with patent-protected, processes for multiple sectors of healthcare. Its product portfolio categories include Wound Care Products, and Surgical and Other Products. Its Wound Care Products include EPIFIX, EPICORD and EPIEFFECT, which are all marketed for external use, such as in advanced wound care applications. Its Surgical and Other product offering includes AMNIOFIX, AMNIOCORD and AMNIOEFFECT, which are positioned for use in a variety of applications and surgical settings, including lower extremity repair, plastic surgery, vascular surgery and multiple orthopedic repairs and reconstructions. The Company's platform technologies include tissue allografts derived from the human placental membrane, tissue allografts derived from the human umbilical cord, and a particulate extracellular matrix derived from the human placental disc.
Ticker SymbolMDXG
CompanyMiMedx Group Inc
CEOMr. Joseph H. (Joe) Capper
Websitehttps://mimedx.com/
KeyAI